title: Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
authors.affiliation: Department of Internal Medicine III, University of Ulm, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Heimpel
authors.forename: N C
authors.initials: NC
authors.lastname: Allan
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
authors.forename: F
authors.initials: F
authors.lastname: Guilhot
authors.forename: R
authors.initials: R
authors.lastname: Hehlmann
authors.forename: M
authors.initials: M
authors.lastname: Horowitz
authors.forename: J
authors.initials: J
authors.lastname: Kluin-Nelemans
authors.forename: U
authors.initials: U
authors.lastname: Schaefer
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: J
authors.initials: J
authors.lastname: Thaler
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha; D006918:Hydroxyurea